Related references
Note: Only part of the references are listed.The diagnostic utility of targeted gene panel sequencing in discriminating etiologies of cytopenia
Gang Zheng et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
Christopher J. Gibson et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists
Marilyn M. Li et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions
Peter Valent et al.
ONCOTARGET (2017)
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
Catherine C. Coombs et al.
CELL STEM CELL (2017)
Increased Multinucleated Megakaryocytes as an isolated Finding in Bone Marrow A Rare Finding and Its Clinical Significance
Majd D. Jawad et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2016)
Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: Difficulties in the assessment of dysplasia
Jean E. Goasguen et al.
LEUKEMIA RESEARCH (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes
M. G. Della Porta et al.
LEUKEMIA (2015)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification
P. Font et al.
ANNALS OF HEMATOLOGY (2013)
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Elli Papaemmanuil et al.
BLOOD (2013)
Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes
Leonor Senent et al.
HAEMATOLOGICA (2013)
Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors
Stefani Parmentier et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Dusseldorf Registry on myelodysplastic syndromes
Ulrich Germing et al.
LEUKEMIA RESEARCH (2012)
Pseudo-Pelger-Fluet Anomaly Induced by Medications A Clinicopathologic Study in Comparison With Myelodysplastic Syndrome-Related Pseudo-Pelger-Huet Anomaly
Endi Wang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Myelodysplastic features in visceral leishmaniasis
N Yarali et al.
AMERICAN JOURNAL OF HEMATOLOGY (2002)
Share Paper
